Behrman Capital Portfolio Company Atherotech, Inc. Completes Recapitalization

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--Behrman Capital, a private equity investment firm based in New York and San Francisco, today announced that its portfolio company Atherotech has completed a dividend recapitalization. Behrman Capital acquired Atherotech, a Birmingham, Alabama-based provider of advanced cardiometabolic testing services, in December 2010.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC